10X Genomics (TXG) Stock
NASDAQ · TXG
79.10
Fundamentals
Market cap
$9.98B
Price / Earnings ratio
-132.8x
Price / Sales ratio
16.2x
Price / Book ratio
12.1x
Return on assets
-0.0%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About 10X Genomics
We are a life science technology company building products to interrogate, understand and master biology. Our integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. We have built deep expertise across diverse disciplines including chemistry, biology, hardware and software.
SectorHealthcare
IndustryHealth Information Services
Employees1,178
CEODr. Serge Saxonov Ph.D.
IPO DateSep 12, 2019
HeadquartersPleasanton, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Serge Saxonov Ph.D. | Co-Founder, CEO & Director | 1977 |
| Dr. Benjamin J. Hindson Ph.D. | Co-Founder, President, Chief Scientific Officer & Director | 1975 |
| Mr. Adam S. Taich | CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer | 1975 |
| Mr. Jim Goodrich | Chief of Global Operations | — |
| Mr. Michael Schnall-Levin Ph.D. | Founding Scientist & CTO | — |
| Ms. Cassie Corneau | Manager of Investor Relations & Strategic Finance | — |
| Dr. Randy Wu | General Counsel and Secretary | — |
| Ms. Mennah Moustafa | Chief Commercial Officer | — |
| Mr. Jens Durruthy | Associate Director of Product Management | — |
Fundamentals
Valuation
Market cap$9.98B
Price-to-sales ratio16.18
Price-to-book value12.09
Price-earnings ratio-132.80
Return on Equity-3.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-0.59
Income Statement
Average volume2,777,974
EBITDA$26.66M
1 year high (52w)$79.94
1 year low (52w)$11.16
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



